Clous

bioAffinity Technologies, Inc.

Nasdaq: BIAF

Services-Commercial Physical & Biological Research · Entity-resolved by Clous

CIK0001712762
TickerBIAF
ExchangeNasdaq
SIC8731
StateDE
FY end12-31

Illustrative profile — live data lights up when a server API key is configured.

Key financials

RevenueFY2025-12-31
$6.16M
-34.2% YoY
Net IncomeFY2025-12-31
-$14.91M
-64.9% YoY
Total AssetsFY2025-12-31
$10.96M
+68.3% YoY
EquityFY2025-12-31
$7.28M
+179.7% YoY
Shares OutstandingFY2025-12-31
4.5M
Operating Cash FlowFY2025-12-31
-$9.33M
-28.4% YoY

Market

Market
BIAF
Close price
$0.84
Market cap
$3.8M
delayed EOD · as of 2026-06-18
ConceptFY2022-12-31FY2023-12-31FY2024-12-31FY2025-12-31YoY% rev
Revenue$4.8K$2.53M$9.36M$6.16M-34.2%100%
Net Income-$8.15M-$7.94M-$9.04M-$14.91M-64.9%-242%
Total Assets$12.18M$8.22M$6.51M$10.96M+68.3%178%
Equity$11.04M$4.86M$2.6M$7.28M+179.7%118%
Operating Cash Flow-$4.07M-$6.04M-$7.26M-$9.33M-28.4%-151%
Shares Outstanding4.5M
Source: SEC EDGAR · resolved by Clous · as of 2026-05-30Warehouse synced 2026-06-20 06:30 UTC

Get this entity — and 970.89K+ others — programmatically.

One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.

GET /v1/entities?cik=0001712762